MicroRNA-21: a therapeutic target for reversing drug resistance in cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.9, 2013-09, pp. : 1073-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 745-764

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA-21 with therapeutic potential in autoimmune diseases

By Xu Wang-Dong

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 659-665

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-21: From Cancer to Cardiovascular Disease

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 926-935

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance

Current Pharmaceutical Design, Vol. 22, Iss. 7, 2016-02 ,pp. : 933-939

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA miR-122 as a Therapeutic Target for Oligonucleotides and Small Molecules

Current Medicinal Chemistry, Vol. 20, Iss. 29, 2013-09 ,pp. : 3629-3640

Bentham Science Publishers

Access to resources Recommend Favorite